4.8 Article

Identification and Single-Cell Analysis of Viable Circulating Tumor Cells by a Mitochondrion-Specific AIE Bioprobe

Journal

ADVANCED SCIENCE
Volume 7, Issue 4, Pages -

Publisher

WILEY
DOI: 10.1002/advs.201902760

Keywords

aggregation-induced emission; circulating tumor cells; fluorescent probes; single-cell analysis

Funding

  1. National Natural Science Foundation of China [81672076, 81802116, 81871735]
  2. Medical Science and Technology Research Foundation of Guangdong Province [A2017326]
  3. Science and Technology Program of Guangzhou [201510010097]
  4. Major Program of Health Care and Innovation of Guangzhou Project [201704020213, 201604020015]
  5. Major Scientific and Technological Special Project in the Precision Medical Field of Guangdong Province [2019B020232003]
  6. Health Care Collaborative Innovation Major Project of Guangzhou Municipality [201604020014]
  7. Outstanding Youths Development Scheme of Nanfang Hospital, Southern Medical University [2018J002]
  8. Outstanding Youths Development Scheme of Southern Medical University [2019YQPY007]

Ask authors/readers for more resources

Liquid biopsies of cancer via single-cell molecular profiling of circulating tumor cells (CTCs) are hampered by the lack of ideal CTC markers. In this study, it is reported that TPN, a bioprobe with aggregation-induced emission (AIE) activity is capable of distinguishing various tumor cells from blood leukocytes based on the difference in cell mitochondria. TPN is a cell-permeant live-cell stain that has little effect on cell viability and integrity, enabling single-cell DNA/RNA analysis with improved efficiency compared with traditional antibody-based methods. Using TPN labeling, CTCs and CTC cluster are detected in the blood from patients with lung or liver cancer. The capability of TPN to identify rare tumor cells in the malignant pleural effusion samples is also demonstrated. Furthermore, RNA sequencing of single lung CTC identified by TPN is successfully performed. The findings presented here provide an antibody-free, low-cost, and nondisruptive approach for detection and genomic characterization of viable tumor cells based on a mitochondria-targeting AIE luminogen. It might serve as a new tool for monitoring of genomics dynamic of tumor and unraveling the mechanisms of tumor metastasis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available